The treatment of Backache & Gout with vitamins

Backache and Gout: Mitamins custom make quality formulas for the treatment of Backache & Gout with vitamins. A Backache & Gout formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Backache and Gout

  • Amount Per Serving
    % DV
    Vitamin C
    200
    mg
    333%
    Folate
    400
    mcg
    100%
    Vitamin B12
    50
    mcg
    833%
    Calcium
    50
    mg
    5%
    Magnesium
    25
    mg
    6%
    Potassium
    50
    mg
    1%
    Flax Seed Powder
    50
    mg
    *
    Blueberry Extract
    50
    mg
    *
  • Amount Per Serving
    % DV
    Feverfew Extract
    50
    mg
    *
    Nettle Extract
    50
    mg
    *
    Quercetin
    100
    mg
    *
    DL-Phenylalanine
    100
    mg
    *
    White Willow Extract
    30
    mg
    *
    Bromelain
    100
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Backache and Gout
Monthly Cost: $20.42
Serving Size:4-5
30 Days Money Back Guarantee
100% Satisfaction Guarantee

Backache and Gout Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
Update This Formula
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Immunosuppressive Risks In Facial Transplantation
Researchers in Cincinnati and Louisville report that immunosuppressive risks associated with facial transplantation may be lower than thought, possibly making the procedure a safer option for people who have suffered severe facial injuries.
InterMune Announces Start Of Phase 1b Trial Of ITMN-191
InterMune, Inc. (Nasdaq: ITMN) announced that the company has begun dosing the first patients in their Phase 1b multiple ascending dose (MAD) clinical trial evaluating ITMN-191 (also called R7227) in patients with chronic hepatitis C. ITMN-191 is a hepatitis C virus (HCV) protease inhibitor in development by InterMune and its partner, Roche. InterMune also reported additional information from its recently completed Phase 1a clinical trial of ITMN-191.
This information concerning the support of Backache and Gout treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Mitamins Logo
Home  Multi-Conditions formulas  Pain & Migraine  Backache  Backache and Gout
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments